Abstract
Streptomyces venezuelae ATCC 15439, which produces 12- and 14-membered ring macrolide antibiotics, is a platform strain for heterologous expression of secondary metabolites. Its 9.05-Mb genome sequence revealed an abundance of genes involved in the biosynthesis of secondary metabolites and their precursors, which should be useful for the production of bioactive compounds.
| Original language | English |
|---|---|
| Pages (from-to) | 57-58 |
| Number of pages | 2 |
| Journal | Journal of Biotechnology |
| Volume | 219 |
| DOIs | |
| Publication status | Published - 2016 Feb 10 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Biotechnology
- Applied Microbiology and Biotechnology
Cite this
}
Complete genome sequence of Streptomyces venezuelae ATCC 15439, a promising cell factory for production of secondary metabolites. / Song, Ju Yeon; Yoo, Young Ji; Lim, Si Kyu; Cha, Sun Ho; Kim, Ji Eun; Roe, Jung Hye; Kim, Jihyun F.; Yoon, Yeo Joon.
In: Journal of Biotechnology, Vol. 219, 10.02.2016, p. 57-58.Research output: Contribution to journal › Article
TY - JOUR
T1 - Complete genome sequence of Streptomyces venezuelae ATCC 15439, a promising cell factory for production of secondary metabolites
AU - Song, Ju Yeon
AU - Yoo, Young Ji
AU - Lim, Si Kyu
AU - Cha, Sun Ho
AU - Kim, Ji Eun
AU - Roe, Jung Hye
AU - Kim, Jihyun F.
AU - Yoon, Yeo Joon
PY - 2016/2/10
Y1 - 2016/2/10
N2 - Streptomyces venezuelae ATCC 15439, which produces 12- and 14-membered ring macrolide antibiotics, is a platform strain for heterologous expression of secondary metabolites. Its 9.05-Mb genome sequence revealed an abundance of genes involved in the biosynthesis of secondary metabolites and their precursors, which should be useful for the production of bioactive compounds.
AB - Streptomyces venezuelae ATCC 15439, which produces 12- and 14-membered ring macrolide antibiotics, is a platform strain for heterologous expression of secondary metabolites. Its 9.05-Mb genome sequence revealed an abundance of genes involved in the biosynthesis of secondary metabolites and their precursors, which should be useful for the production of bioactive compounds.
UR - http://www.scopus.com/inward/record.url?scp=84951765364&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84951765364&partnerID=8YFLogxK
U2 - 10.1016/j.jbiotec.2015.12.028
DO - 10.1016/j.jbiotec.2015.12.028
M3 - Article
VL - 219
SP - 57
EP - 58
JO - Journal of Biotechnology
JF - Journal of Biotechnology
SN - 0168-1656
ER -